A new study by American Cancer Society researchers finds medical financial hardship is common among people in the U.S., with more than half reporting problems with affordability, stress, or delaying care because of cost.
In his new book, “No More Tears: The Dark Secrets of Johnson & Johnson,” Gardiner Harris, who was previously the public health and pharmaceutical business reporter for The New York Times, talks about the history of the overuse of red blood cell growth factors in oncology.
